New zap-and-heal catheter aims to fix irregular heartbeat without long-term drugs

NCT ID NCT06696170

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new device called the CellFX Nano-PFA 360 catheter, which uses very short electrical pulses to treat atrial fibrillation (an irregular heartbeat). About 60 adults aged 18 to 75 with paroxysmal atrial fibrillation will receive this procedure. The goal is to see if it is safe and can restore normal heart rhythm by blocking faulty electrical signals in the heart.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION PAROXYSMAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Arrhythmias, Cardiac atrial fibrillation paroxysmal atrial fibrillation ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hartcentrum Hasselt Research Center /Jessa Hospital

    ACTIVE_NOT_RECRUITING

    Hasselt, Belgium

  • Na Homolce Hospital

    RECRUITING

    Prague, Czechia

    Contact

    Contact

  • Policlinico Tor Vergata Hospital

    RECRUITING

    Roma, Italy

    Contact

    Contact